MPP – Afrigen Biologics, RSV mRNA-Based Vaccine, Grant Agreement Post author:GHIAA Admin Post published:December 3, 2024 Post category: Continue ReadingMPP – Afrigen Biologics, RSV mRNA-Based Vaccine, Grant Agreement
Spinal Muscular Atrophy Foundation – PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement Post author:GHIAA Admin Post published:December 2, 2024 Post category: Continue ReadingSpinal Muscular Atrophy Foundation – PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
AbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir – LPV/r) Pediatric License Agreement Post author:GHIAA Admin Post published:November 4, 2024 Post category: Continue ReadingAbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir – LPV/r) Pediatric License Agreement
Wellcome Trust – Alto Neuroscience, Bipolar Depression Therapeutic Convertible Loan Agreement Post author:GHIAA Admin Post published:October 7, 2024 Post category: Continue ReadingWellcome Trust – Alto Neuroscience, Bipolar Depression Therapeutic Convertible Loan Agreement
CEPI – University of Oxford – Barinthus Biotherapeutics, ChAdOx1 MERS Vaccine R&D Funding Agreement Post author:GHIAA Admin Post published:September 2, 2024 Post category: Continue ReadingCEPI – University of Oxford – Barinthus Biotherapeutics, ChAdOx1 MERS Vaccine R&D Funding Agreement
Gates Foundation – BioNTech, TB & HIV Product Strategic Letter Agreement Post author:GHIAA Admin Post published:July 12, 2024 Post category: Continue ReadingGates Foundation – BioNTech, TB & HIV Product Strategic Letter Agreement
Pfizer – MPP, TB Therapeutic (Sutezolid) Non-Exclusive License Agreement Post author:GHIAA Admin Post published:May 30, 2024 Post category: Continue ReadingPfizer – MPP, TB Therapeutic (Sutezolid) Non-Exclusive License Agreement
MPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement Post author:GHIAA Admin Post published:May 30, 2024 Post category: Continue ReadingMPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement
NIAID – AbCellera, COVID-19 Exclusive Patent License Agreement Post author:GHIAA Admin Post published:April 11, 2024 Post category: Continue ReadingNIAID – AbCellera, COVID-19 Exclusive Patent License Agreement